ArticleCureus2026
Outcome Analysis of Palliative Endoscopic Biliary Stenting (EBS) for Frail Elderly Patients Aged 80 Years and Above With Choledocholithiasis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aims to retrospectively analyse the outcome of palliative endoscopic biliary stenting (EBS) in very elderly patients aged 80 years and above with choledocholithiasis.
methodsBetween September 2017 and January 2022, the endoscopy unit at Universiti Malaya Medical Centre (UMMC) conducted 85 ERCP procedures on patients aged 80 and above, who had been diagnosed with choledocholithiasis. The study sample was narrowed down to 11 patients who had received palliative EBS after excluding cases where stone removal was done and patients undergoing active management. Information regarding the patients' medical records, including their past medical history, details of the endoscopic retrograde cholangiopancreatography (ERCP) procedure with palliative EBS, and their subsequent follow-up records, was gathered from the UMMC electronic medical record.
resultsOut of the 11 patients included in the study, six patients (54.44%) experienced recurrent cholangitis, with a median interval of 534 days from the date of index ERCP to the onset of the first recurrence. Two of the six patients (33.33%) who experienced recurrence were able to achieve stone clearance after undergoing repeat ERCP. Among the five patients who remained recurrence-free, the median follow-up duration was 120 days. In addition, out of the study cohort, seven patients (63.64%) passed away during the follow-up period, with only one patient (14.29%) dying due to recurrent cholangitis, while the other six patients (85.71%) died of their co-morbidities.
conclusionERCP with palliative EBS can be a feasible alternative for very elderly patients with complex medical issues; however, it is imperative to ensure close follow-up and careful monitoring during the post-treatment period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.